Clinical Trial Update: First-Line Chemotherapy and Panitumumab in Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating first-line chemotherapy with panitumumab in advanced non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Vejle Hospital | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED